Q-omics provides the consensus-scored SNORA35 profile across patient tissues and cancer cell-line models. SNORA35 expression is associated with patient survival in 3 of 34 cancer types, with the highest sampling consensus in SKCM. Additionally, SNORA35 RNA expression shows 5,141 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight SKCM, and STAD as cancer lineages where SNORA35 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.